The financials
Stryker Corporation by the numbers
Stryker Corporation (SYK) reported revenue of $6.59B in Q2 2026 (quarter ended June 30, 2026), up 9.4% from the same quarter a year earlier. That came with a gross margin of 68% and net income of $1.28B (19% of revenue). For the full year FY2025, revenue was $25.1B (+11% year on year) and net income $3.25B. Its largest product in 2026-Q1 was Instruments at $920M, 15% of the disclosed total, just ahead of Medical at 14%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $6.59B | $6.02B | +9.4% |
| Gross profit | $4.50B | $3.84B | +17% |
| Operating income | $1.66B | $1.11B | +49% |
| Net income | $1.28B | $884M | +44% |
| Diluted EPS | $3.30 | $2.29 | +44% |
| Product | Revenue | Share |
|---|---|---|
| Instruments | $920M | 15% |
| Medical | $902M | 14% |
| Endoscopy | $868M | 14% |
| Knees | $670M | 11% |
| Ortho Tech | $646M | 10% |
| Neuro Cranial Instruments | $606M | 9.7% |
| Neurovascular | $517M | 8.3% |
| Orthopaedic Instruments | $489M | 7.8% |
| Hips | $460M | 7.3% |
| Other Orthopedics | $157M | 2.5% |
| Enabling Technologies | $26M | 0.4% |
| Spinal Implants | $2.0M | 0.0% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $6.26B (+23%)
Neurovascular grew +27% year on yearSpinal Implants -99% year on year
Segment Latestquarter on quarteryear on year
- Instruments$920.0M$920.0MQoQ +21%year on year +9.8%+21%+9.8%
- Medical$902.0M$902.0MQoQ -8.4%year on year -4.6%-8.4%-4.6%
- Endoscopy$868.0M$868.0MQoQ -3.1%year on year +0.12%-3.1%+0.12%
- Knees$670.0M$670.0MQoQ +6.7%year on year +4.9%+6.7%+4.9%
- Ortho Tech$646.0M$646.0MQoQ -year on year +4.7%-+4.7%
- Neuro Cranial Instruments$606.0M$606.0MQoQ -year on year +7.6%-+7.6%
- Neurovascular$517.0M$517.0MQoQ -1.5%year on year +27%-1.5%+27%
- Orthopaedic Instruments$489.0M$489.0MQoQ -year on year +1.0%-+1.0%
- Hips$460.0M$460.0MQoQ +0.66%year on year +3.8%+0.66%+3.8%
- Other Orthopedics$157.0M$157.0MQoQ -year on year +18%-+18%
- Enabling Technologies$26.0M$26.0MQoQ -year on year -10%--10%
- Spinal Implants$2.0M$2.0MQoQ -year on year -99%--99%
- Neuro Cranial Interventional Spine--QoQ -year on year ---
- Neuro Cranial--QoQ -year on year ---
- Other Orthopaedics--QoQ -year on year ---
- Other Orthopedics Enabling Technologies--QoQ -year on year ---
- Spine--QoQ -year on year ---
Medical Devices
Ranks #17 of 35 by Smart Score